Weiming Du

Observer
DISC Type : ci

Associate Director Biostatistics Medical Affairs at Alnylam Pharmaceuticals

Piscataway, New Jersey, United States

Overview

Weiming Du is an Associate Director of Biostatistics at Alnylam Pharmaceuticals, specializing in medical affairs for the Global Rare Disease Franchise. A graduate of Rutgers University, he has deep expertise in machine learning and data science, holding certifications as a Certified Advanced Programmer for SAS 9.

His background includes significant time at Regeneron, where he led medical analytics for the ophthalmology franchise. Weimings journey began with a Bachelors degree in Management from Sun Yat-sen University, indicating a foundation in both business and quantitative analysis, and a multicultural background.

Unique fact: Weiming led a dedicated machine learning group at Regeneron, applying advanced methods like neural networks and deep learning to medical data.

Personality Overview

Assertive

Curious

Example Seeker

They are likely to ask many questions and look heavily for supporting information.  They are generally strong communicators and are not easy to convince. They can sound friendly and charming but can quickly change gears to become inquisitive and probing.

Topics They Care About

Rare Disease Analytics
As the Biostatistics Lead for Alnylam's Global Rare Disease Franchise, he is deeply involved in statistical strategy for conditions like Primary Hyperoxaluria type 1 (PH1).
Machine Learning in Pharma
He has a stated "deep knowledge" of machine learning methods and led a group at Regeneron focused on applying AI/ML to medical analytics.
Ophthalmology Research
Previously served as the Global Medical Analytics Lead for Regeneron's Ophthalmology Franchise and co-authored research on Neovascular AMD.

Media Appearances

Weiming has no verified media appearances

Work History

5-2023
Associate Director Biostatistics Medical Affairs at Alnylam Pharmaceuticals
1-2023 - 4-2023
Senior Manager Medical Analytics, Medical Affairs at Regeneron
1-2022 - 12-2022
Manager Medical Analytics, Medical Affairs at Regeneron
1-2020 - 12-2021
Associate Manager Medical Analytics, Medical Affairs at Regeneron
9-2014 - 1-2018
Senior Statistical Programmer at BDM Consulting, Inc

Education

2012 - 2014
Master of Science (MS) from Rutgers University
2003 - 2007
Bachelor of Management from Sun Yat-sen University

More Information

Social Presence :

Prographics :

Exp : 9 Location : Piscataway, New Jersey, United States Job Level : Mid-senior Designation : Associate Director Biostatistics Medical Affairs at Alnylam Pharmaceuticals
URL has been copied!

Insights For Selling To Weiming

During A Call Or A Meeting

DO's

  • Focus on immediate action-items rather than the larger goals
  • Invite them for a social do but don’t rely solely on the relationship
  • Help them understand the risk aspect fully while inspiring confidence

DONT's

  • Don’t brush off any concerns, take all questions seriously
  • Don’t be too objective but make sure to pad your storytelling with data points
  • Don’t rely excessively on your relationship with them to win the deal

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Weiming is

  • Proven value, strong testimonials are important to them, relationships will have some weightage.
  • Will you ever get a clear answer from Weiming

  • They are practical yet friendly, don’t expect a clear no very often.

Insights For Deal Planning

    How fast (or slow) will Weiming move?

  • They like to analyze well and can take their time to reach any decisions.
  • Can Weiming take some risk or not?

  • They evaluate their decisions systematically and are less likely to take risks.

You And Weiming

Personality Compatibility


Other Alnylam Pharmaceuticals Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.